AXGN Axogen Inc

Price (delayed)

$10.39

Market cap

$439.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.74

Enterprise value

$493.81M

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore ...

Highlights

Axogen's net income has decreased by 44% YoY

Axogen's quick ratio has decreased by 38% YoY and by 11% from the previous quarter

Sector: Healthcare

Industry: Medical Devices

Website: http://www.axogeninc.com

Peers: MDT TMO BSX

Key stats

What are the main financial stats of AXGN

Market

Shares outstanding

42.28M

Market cap

$439.33M

Enterprise value

$493.81M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

4.29

Price to sales (P/S)

3.4

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.85

Earnings

Revenue

$128.2M

EBIT

-$30.69M

EBITDA

-$26M

Free cash flow

-$44.6M

Per share

EPS

-$0.74

Free cash flow per share

-$1.06

Book value per share

$2.42

Revenue per share

$3.05

TBVPS

$4.59

Balance sheet

Total assets

$196.08M

Total liabilities

$94.39M

Debt

$72.56M

Equity

$101.69M

Working capital

$83.18M

Liquidity

Debt to equity

0.71

Current ratio

4.52

Quick ratio

3.59

Net debt/EBITDA

-2.1

Margins

EBITDA margin

-20.3%

Gross margin

82.5%

Net margin

-24.7%

Operating margin

-24.4%

Efficiency

Return on assets

-15.6%

Return on equity

-29.2%

Return on invested capital

-14.2%

Return on capital employed

-17.8%

Return on sales

-23.9%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

AXGN stock price

How has the Axogen stock price performed over time

Intraday

-1.61%

1 week

6.56%

1 month

23.1%

1 year

-43.07%

YTD

10.89%

QTD

26.86%

Financial performance

How have Axogen's revenue and profit performed over time

Revenue

$128.2M

Gross profit

$105.71M

Operating income

-$31.29M

Net income

-$31.64M

Gross margin

82.5%

Net margin

-24.7%

AXGN's operating margin has shrunk by 61% YoY

Axogen's operating income has plunged by 58% YoY and by 2.5% from the previous quarter

The company's net margin fell by 46% YoY

Axogen's net income has decreased by 44% YoY

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation

P/E

N/A

P/B

4.29

P/S

3.4

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

3.85

The company's EPS fell by 37% YoY

AXGN's P/B is 66% below its 5-year quarterly average of 12.5 but 10% above its last 4 quarters average of 3.9

The equity has decreased by 14% YoY and by 2.1% QoQ

AXGN's P/S is 61% below its 5-year quarterly average of 8.7

Efficiency

How efficient is Axogen business performance

Axogen's ROE has plunged by 60% YoY and by 3.5% from the previous quarter

The company's return on sales has shrunk by 55% YoY

The ROA has decreased by 42% YoY

Axogen's return on invested capital has decreased by 28% YoY but it has increased by 2.1% QoQ

Dividends

What is AXGN's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time

The total assets is 108% higher than the total liabilities

Axogen's quick ratio has decreased by 38% YoY and by 11% from the previous quarter

AXGN's current ratio is down by 31% year-on-year and by 8% since the previous quarter

The company's debt is 29% lower than its equity

The debt to equity has grown by 16% YoY

The equity has decreased by 14% YoY and by 2.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.